Exact Sciences
EXAS
#1167
Rank
โ‚น1.886 T
Marketcap
โ‚น9,885
Share price
0.00%
Change (1 day)
153.87%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -โ‚น15.95 Billion

According to Exact Sciences's latest financial reports the company's current earnings are โ‚น3.24 Billion. , an increase over its 2024 earnings that were of -โ‚น95.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น17.17 Billion-82.05%
2024 -โ‚น95.68 Billion435.05%
2023 -โ‚น17.89 Billion-69.18%
2022 -โ‚น58.03 Billion-25.77%
2021 -โ‚น78.17 Billion1.68%
2020 -โ‚น76.88 Billion271.17%
2019 -โ‚น20.72 Billion58.99%
2018 -โ‚น13.03 Billion20.89%
2017 -โ‚น10.78 Billion-30.95%
2016 -โ‚น15.61 Billion5.09%
2015 -โ‚น14.86 Billion57.24%
2014 -โ‚น9.45 Billion116.53%
2013 -โ‚น4.37 Billion
2011 -โ‚น2.72 Billion143.73%
2010 -โ‚น1.12 Billion27.85%
2009 -โ‚น0.88 Billion0.27%
2008 -โ‚น0.87 Billion-20.95%
2007 -โ‚น1.1 Billion-13.53%
2006 -โ‚น1.28 Billion-10.07%
2005 -โ‚น1.42 Billion-21.81%
2004 -โ‚น1.81 Billion-33.44%
2003 -โ‚น2.72 Billion-6.51%
2002 -โ‚น2.91 Billion17.95%
2001 -โ‚น2.47 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚น725.42 B-4,325.25%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
โ‚น5.83 B-133.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚น6.20 B-136.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น39.44 Billion 129.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚น3.3 Billion-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA